SEARCH

SEARCH BY CITATION

References

  • Van Den Berg, C.W., Taylor, K.E. & Lang, D. (2004) C-reactive protein-induced in vitro vasorelaxation is an artefact caused by the presence of sodium azide in commercial preparations. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, e168e171.
  • Bisoendial, R.J., Kastelein, J.J., Levels, J.H., Zwaginga, J.J., Van Den Bogaard, B., Reitsma, P.H., Meijers, J.C., Hartman, D., Levi, M. & Stroes, E.S. (2005) Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circulation Research, 96, 714716.
  • Black, S., Kushner, I. & Samols, D. (2004) C-reactive protein. Journal of Biological Chemistry, 279, 4848748490.
  • Blann, A.D. & Lip, G.Y. (2003) Effects of C-reactive protein on the release of von Willebrand factor, E-selectin, thrombomodulin and intercellular adhesion molecule-1 from human umbilical vein endothelial cells. Blood Coagulation and Fibrinolysis, 14, 335340.
  • Bombeli, T., Schwartz, B.R. & Harlan, J.M. (1998) Adhesion of activated platelets to endothelial cells: evidence for a GPIIbIIIa-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (ICAM-1), alphavbeta3 integrin, and GPIbalpha. Journal of Experimental Medicine, 187, 329339.
  • Clapp, B.R., Hirschfield, G.M., Storry, C., Gallimore, J.R., Stidwill, R.P., Singer, M., Deanfield, J.E., MacAllister, R.J., Pepys, M.B., Vallance, P. & Hingorani, A.D. (2005) Inflammation and endothelial function: direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation, 111, 15301536.
  • Cominacini, L., Fratta Pasini, A., Garbin, U., Pastorino, A., Rigoni, A., Nava, C., Davoli, A., Lo Cascio, V. & Sawamura, T. (2003) The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells. Journal of the American College of Cardiology, 41, 499507.
  • Danenberg, H.D., Szalai, A.J., Swaminathan, R.V., Peng, L., Chen, Z., Seifert, P., Fay, W.P., Simon, D.I. & Edelman, E.R. (2003) Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice. Circulation, 108, 512515.
  • Danesh, J., Wheeler, J.G., Hirschfield, G.M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G.D., Pepys, M.B. & Gudnason, V. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New England Journal of Medicine, 350, 13871397.
  • Fiedel, B.A. & Gewurz, H. (1976a) Effects of C-reactive protein on platelet function. I. Inhibition of platelet aggregation and release reactions. Journal of Immunology, 116, 12891294.
  • Fiedel, B.A. & Gewurz, H. (1976b) Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen. Journal of Immunology, 117, 10731078.
  • Fiedel, B.A., Simpson, R.M. & Gewurz, H. (1982) Effects of C-reactive protein (CRP) on platelet function. Annals of the New York Academy of Sciences, 389, 263273.
  • Haverkate, F., Thompson, S.G., Pyke, S.D., Gallimore, J.R. & Pepys, M.B. (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet, 349, 462466.
  • Ikeda, U., Takahashi, M. & Shimada, K. (2003) C-reactive protein directly inhibits nitric oxide production by cytokine-stimulated vascular smooth muscle cells. Journal of Cardiovascular Pharmacology, 42, 607611.
  • Khreiss, T., Jozsef, L., Hossain, S., Chan, J.S., Potempa, L.A. & Filep, J.G. (2002) Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. Journal of Biological Chemistry, 277, 4077540781.
  • Lafuente, N., Azcutia, V., Matesanz, N., Cercas, E., Rodriguez-Manas, L., Sanchez-Ferrer, C.F. & Peiro, C. (2005) Evidence for sodium azide as an artifact mediating the modulation of inducible nitric oxide synthase by C-reactive protein. Journal of Cardiovascular Pharmacology, 45, 193196.
  • Libby, P. & Simon, D.I. (2001) Inflammation and thrombosis: the clot thickens. Circulation, 103, 17181720.
  • Parker, P.J. & Murray-Rust, J. (2004) PKC at a glance. Journal of Cell Science, 117, 131132.
  • Pasceri, V., Willerson, J.T. & Yeh, E.T. (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation, 102, 21652168.
  • Pasceri, V., Cheng, J.S., Willerson, J.T. & Yeh, E.T. (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation, 103, 25312534.
  • Pearson, T.A., Mensah, G.A., Alexander, R.W., Anderson, J.L., Cannon, III, R.O., Criqui, M., Fadl, Y.Y., Fortmann, S.P., Hong, Y., Myers, G.L., Rifai, N., Smith, Jr, S.C., Taubert, K., Tracy, R.P. & Vinicor, F. (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 107, 499511.
  • Ridker, P.M. (2002) Inflammatory biomarkers, statins, and the risk of stroke: cracking a clinical conundrum. Circulation, 105, 25832585.
  • Ridker, P.M., Hennekens, C.H., Buring, J.E. & Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342, 836843.
  • Ridker, P.M., Rifai, N., Rose, L., Buring, J.E. & Cook, N.R. (2002) Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England Journal of Medicine, 347, 15571565.
  • Swafford, Jr, A.N., Bratz, I.N., Knudson, J.D., Rogers, P.A., Timmerman, J.M., Tune, J.D. & Dick, G.M. (2005) C-reactive protein does not relax vascular smooth muscle: effects mediated by sodium azide in commercially available preparations. American Journal of Physiology. Heart and Circular Physiology, 288, H1786H1795.
  • Szalai, A.J. & McCrory, M.A. (2002) Varied biologic functions of C-reactive protein: lessons learned from transgenic mice. Immunologic Research, 26, 279287.
  • Szalai, A.J., Briles, D.E. & Volanakis, J.E. (1995) Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. Journal of Immunology, 155, 25572563.
  • Tatin, F., Varon, C., Genot, E. & Moreau, V. (2006) A signalling cascade involving PKC, Src and Cdc42 regulates podosome assembly in cultured endothelial cells in response to phorbol ester. Journal of Cell Science, 119, 769781.
  • Taylor, K.E., Giddings, J.C. & Van Den Berg, C.W. (2005) C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 12251230.
  • Varon, D., Dardik, R., Shenkman, B., Kotev-Emeth, S., Farzame, N., Tamarin, I. & Savion, N. (1997) A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thrombosis Research, 85, 283294.
  • Venugopal, S.K., Devaraj, S., Yuhanna, I., Shaul, P. & Jialal, I. (2002) Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation, 106, 14391441.
  • Verma, S., Wang, C.H., Li, S.H., Dumont, A.S., Fedak, P.W., Badiwala, M.V., Dhillon, B., Weisel, R.D., Li, R.K., Mickle, D.A. & Stewart, D.J. (2002a) A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation, 106, 913919.
  • Verma, S., Li, S.H., Badiwala, M.V., Weisel, R.D., Fedak, P.W., Li, R.K., Dhillon, B. & Mickle, D.A. (2002b) Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 105, 18901896.